| Literature DB >> 31183957 |
Yuzhi Chen1, Wenting Ai1, Xuan Guo2, Yawen Li1, Yufan Ma1, Lifang Chen2, Hui Zhang2, Tongxin Wang3, Xin Zhang2, Zhuo Wang1.
Abstract
Photodynamic therapy (PDT) and photothermal therapy (PTT) are two kinds of treatment for tumors. Herein, a new aggregation-induced emission (AIE)gen (MeO-TPE-indo, MTi) is synthesized with a D-π-A conjugated structure. MTi, which has an electron donor and an acceptor on a tetraphenylethene (TPE) conjugated skeleton, can induce the effective generation of reactive oxygen species (ROS) for PDT. With the guide of the indolium group, MTi can target and image mitochondrion selectively. In order to get good dispersion in water and long-time retention in tumors, MTi is modified on the surface of polydopamine nanoparticles (PDA NPs) to form the nanocomposite (PDA-MeO-TPE-indo, PMTi) by π-π and hydrogen interactions. PMTi is a nanoscale composite for imaging-guided PDT and PTT in tumor treatment, which is constructed with AIEgens and PDA for the first time. The organic functional molecules are combined with nanomaterials for building a multifunctional diagnosis and treatment platform by utilizing the advantages of both sides.Entities:
Keywords: aggregation-induced emission; antitumor agents; mitochondria-target; photodynamic-photothermal synergetic therapeutics; photosensitizers
Mesh:
Substances:
Year: 2019 PMID: 31183957 DOI: 10.1002/smll.201902352
Source DB: PubMed Journal: Small ISSN: 1613-6810 Impact factor: 13.281